Abstract
Pneumonia remains as the leading infectious cause of death in children under 5 years old in the world, especially in developing countries. Despite the availability of pneumococcal conjugate vaccines, these are highly costly, progressively lose their efficiency in the evolutionary phenomenon of serotype substitution, and are not intended to immunize neonates: the most vulnerable infant gro…